Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12104/41757
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKlimov, Andrei B.
dc.contributor.authorRomero, J.L.
dc.contributor.authorBjork, G.
dc.contributor.authorSanchez-Soto, L.L.
dc.date.accessioned2015-09-15T18:03:22Z-
dc.date.available2015-09-15T18:03:22Z-
dc.date.issued2007
dc.identifier.urihttp://hdl.handle.net/20.500.12104/41692-
dc.identifier.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84885696467&partnerID=40&md5=d7a8d6e73a909735dc52cf9a305bb7fd
dc.description.abstractWe propose a unifying phase-space approach to the construction of mutually unbiased bases for a two-qubit system. It is based on an explicit classification of the geometrical structures compatible with the notion of unbiasedness. These consist of bundles of discrete curves intersecting only at the origin and satisfying certain additional properties. We also consider the feasible transformations between different kinds of curves and show that they correspond to local rotations around the Bloch-sphere principal axes. We suggest howto generalize the method to systems in dimensions that are powers of a prime. " 2007 IOP Publishing Ltd.",,,,,,"10.1088/1751-8113/40/14/014",,,"http://hdl.handle.net/20.500.12104/41757","http://www.scopus.com/inward/record.url?eid=2-s2.0-34547800260&partnerID=40&md5=d4b3a1d342f7e85816466dd2f86b5649",,,,,,"14",,"Journal of Physics A: Mathematical and Theoretical",,"3987
dc.description.abstract3998",,"40",,"Scopus
dc.description.abstractWOS",,,,,,,,,,,,"Geometrical approach to mutually unbiased bases",,"Article" "43471","123456789/35008",,"Nastasi-Catanese, J.A., Unidad de Genética, Centro de Microscopía Electrónica, Escuela de Ciencias de la Salud, Universidad de Oriente, Ciudad Bolívar, Bolívar, Venezuela; Padilla-Gutiérrez, J.R., Departamento de Clínicas Médicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Valle, Y., Departamento de Clínicas Médicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Ortega-Gutiérrez, F., Departamento de Cardiología, UMAE Hospital de Especialidades, CMNO - Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico; Gallegos-Arreola, M.P., División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico; Figuera, L.E., División de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico, Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico",,"Nastasi-Catanese, J.A.
dc.description.abstractPadilla-Gutierrez, J.R.
dc.description.abstractValle, Y.
dc.description.abstractOrtega-Gutierrez, F.
dc.description.abstractGallegos-Arreola, M.P.
dc.description.abstractFiguera, L.E.",,"2013",,"Oral anticoagulants of the coumarin type have an inconveniently narrow therapeutic window, making their use difficult. In Mexico, genetic variables that participate in the heterogeneity of the therapeutic response remain poorly investigated. With the focus on warfarin, extensive pharmacogenomic studies have been performed, including those on the CYP450 family and APOE. The objective of this study was to determine the contribution of CYP2C9, CYP2C19, and APOE polymorphisms to the variations in response to the doses of acenocoumarol, which is the main anticoagulant prescribed to the Mexican population. The polymerase chain reaction-restriction fragment length polymorphism method was applied to identify *2 and *3 of CYP2C9, *2 of CYP2C19, and APOE variants. The genetic distribution of every polymorphism tested showed high variability when compared with other populations worldwide. Our results showed statistical differences only in the CYP2C19 gene between the *1*1 and *1*2 groups, with effective acenocoumarol doses of 2.56 1.34 mg/day vs 1.35 0.84 mg/day (P = 0.005), respectively. Multiple regression analysis, including patient age and both the CYP2C9 and CYP2C19 genes, showed that these variables explained more than 20% of the dose variations. This is the first report in Mexico searching for the relationship between CYP450 and APOE polymorphisms and the dose requirements of acenocoumarol. Our results suggest that, in the Mexican population, CYP2C19 is more involved in acenocoumarol metabolism than CYP2C9 and APOE. Besides considering the age factor, pharmacogenetic testing for CYP2C19*2 before initiating acenocoumarol treatment could lead to a safer anticoagulation therapy in Mexican patients. " FUNPEC-RP.
dc.relation.isreferencedbyScopus
dc.relation.isreferencedbyWOS
dc.titleGenetic contribution of CYP2C9, CYP2C19, and APOE variants in acenocoumarol response
dc.typeArticle
dc.identifier.doi10.4238/2013.October.10.7
dc.relation.ispartofjournalGenetics and Molecular Research
dc.relation.ispartofvolume12
dc.relation.ispartofissue4
dc.relation.ispartofpage4413
dc.relation.ispartofpage4421
dc.subject.keywordAcenocoumarol; APOE; CYP2C19; CYP2C9; Genetic polymorphisms; PCR-RFLP
dc.contributor.affiliationKlimov, A.B., Departamento de Física, Universidad de Guadalajara, 44420 Guadalajara, Jalisco, Mexico; Romero, J.L., Departamento de Física, Universidad de Guadalajara, 44420 Guadalajara, Jalisco, Mexico; Bjork, G., School of Information and Communication Technology, Royal Institute of Technology (KTH), Electrum 229, SE-164 40 Kista, Sweden; Sánchez-Soto, L.L., Departamento de óptica, Facultad de Física, Universidad Complutense, 28040 Madrid, Spain
dc.contributor.affiliationKlimov, Andrei B., Universidad de Guadalajara. Centro Universitario de Ciencias Exactas e Ingenierías
Appears in Collections:Producción científica UdeG

Files in This Item:
There are no files associated with this item.


Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.